Senior Computational Chemist

With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.

Apply

The Role

You will have the opportunity to contribute to this high performing cross-functional team who seek to apply their knowledge in the high impact field of improving our capability in drug discovery.

We’ve assembled an exceptionally diverse, talented and spirited team who sincerely enjoy coming to work every single day to bring their ideas and real passion for new technology and medicine discovery. You will work alongside recognised thought leaders at the cross section of Machine Learning and Chemistry data, with plenty of interaction with drug discovery researchers.

You'll become a pioneer within a novel multidisciplinary field combining AI and drug discovery, be given autonomy and freedom to define your own role using state-of-the-art technologies within a supportive and meritocratic flat structure with a plethora of opportunities to build and develop your skills both internally and externally within a company that cares.

‍

Primary Responsibilities

Support drug discovery projects at BenevolentAI manifesting the impact of our own technology platform to successfully progress these projects.
Provide compound design support and data analysis for the Drug Discovery programmes undertaken by BenevolentAI.
Be involved in advances and enhancements made to the Benevolent Platform™, identifying improvements and efficiency gains that can be made.
Collaborate and communicate effectively with members of the Chemoinformatics, Bioinformatics, Drug Discovery, Artificial Intelligence, Data Science, Engineering, UX and Product teams to deliver BenevolentAI corporate strategic goals.

We are looking for someone with

PhD (or equivalent) in computational chemistry, molecular modelling, cheminformatics or a closely-related discipline relevant to drug discovery.
Extensive experience applying computational chemistry and molecular modelling expertise to the successful advancement of drug discovery projects to important milestones.

Prior experience of drug discovery project support, such as implementing compound library design, QSAR, docking, virtual screening, molecular fragmentation, structure-based drug design, pharmacophore generation and analysis, or multi-parameter optimisation.
Experience of working with teams and collaborators across different disciplines and geographies.
A solid understanding of chemical descriptors and property predictors, including their appropriate application and potential pitfalls.
Experience with ligand- and structural-based virtual screening techniques (Docking (e.g. GLIDE, GOLD, AutoDock), pharmacophore screening, shape similarity screening).
Experience in a range of computational chemistry software (e.g. Schrodinger DD suite, MOE, KNIME, Pipeline Pilot).

Basic understanding of machine learning and artificial intelligence.
Innovative ideas and approaches in the Chemoinformatics and Computational Chemistry fields of research, as demonstrated by appropriate publications, presentations, and code contributions to open source projects.
Excellent communicator, especially when working with colleagues from other specialities.

Preferred (but not required) qualifications

Track record of prioritising and initiating new projects and areas of research, integrating data and expertise from multiple sources.
Experience of applying novel approaches to the process of lead identification and optimisation with the aim to significantly increase the overall efficiency of the journey from hypothesis generation to clinical testing. Examples of using novel data analyses or AI approaches in compound design or progression would be an advantage.
Evidence of creative thinking to use novel strategies to move projects to important decision points quickly and efficiently.
Evidence of continued learning and acquisition of new skills to constantly develop your drug discovery knowledge.

‍

We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.

About us

BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.

Want to do a little more research before you apply?

Head over to our Glassdoor page to learn about our benefits, culture and to find out what our team thinks about life at Benevolent. You can also find out more about us on LinkedIn and Twitter.